1. Home /
  2. Europe

Europe

Economist Perspective: No-Deal Brexit Could Stoke Inflation

Economist Perspective: No-Deal Brexit Could Stoke Inflation

UK's inflation is caught in the crosshairs of the Brexit debacle.

Market Movers: Negative Rates and Global Central Banks

Market Movers: Negative Rates and Global Central Banks

Global negative rates, a new normal?

Your Need to Know - Central Banks Moves

Your Need to Know - Central Banks Moves

Both the BOE and BOJ leave their rates unchanged.

Market Movers: Negative Rates and Global Central Banks

Market Movers: Negative Rates and Global Central Banks

Global negative rates, a new normal?

Why Europe Will Feel More Pain From the Oil Market Than the U.S.

Why Europe Will Feel More Pain From the Oil Market Than the U.S.

Europe's economy is already weak and rising oil will make it worse.

3 Reasons Investors Should Avoid European Stocks as Oil Prices Rise

3 Reasons Investors Should Avoid European Stocks as Oil Prices Rise

Europe's major economies are already hurting, but rising energy costs will make it worse, especially for any company dependent on discretionary spending.

It's Time to Grow More Wary of Growth Expectations

It's Time to Grow More Wary of Growth Expectations

GDP and corporate earnings trends are not favorable and increasingly indicate slowing economies here and abroad.

Federal Reserve Will Cut Rates - But What Happens Next?

Federal Reserve Will Cut Rates - But What Happens Next?

Federal Reserve policymakers are expected to vote in favor of cutting the central bank's benchmark target interest rate by at least a quarter-point when their two-day meeting wraps up on Wednesday, even as the U.S. economy continues to defy gravity amid slowing global growth and a dog's breakfast of geopolitical issues.

Alder Biopharmaceuticals Surges on Lundbeck Offer

Alder Biopharmaceuticals Surges on Lundbeck Offer

Alder Biopharmaceuticals surges after rival Danish drugmaker Lundbeck announces plans to acquire the company and its late-stage migraine drug eptinezumab in a deal worth up to $1.95 billion.

ECB Decision Gives TLT a Positive Tilt

ECB Decision Gives TLT a Positive Tilt

Take advantage of the NIRP-induced carry trade with this options trade.